Resultados de la búsqueda 201-210 of 5563 for treatment resistant depression

  1. Mayo Clinic Obstetrics and Gynecology Physician Update - July 2022

    Page 1.

  2. Medicina integral y salud - Ensayos clínicos - Mayo Clinic

    Specifically, thoracic pre-transplant caregivers report stress, symptoms of anxiety or depression, and perceive high caregiver burden. These factors may be ...

  3. Hematología - Ensayos clínicos

    A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma. Rochester, Minn., ...

  4. Hematología y oncología pediátrica - Ensayos clínicos - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  5. Mayo Clinic Digestive Diseases Physician Update e-Edition, April 2015

    Thirty to 40 percent of people treated for GERD fail to respond to PPI therapy. ... ½ a success rate unmatched by any other treatment option. Chromoendoscopy ...

  6. Estimulación cerebral profunda - Médicos y departamentos - Mayo Clinic

    Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression: A systematic review focused on the long-term antidepressive effect.

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...

  8. Clinical Update - July 2009 - MC2024-0709

    Page 1. Page 2. Page 3. Page 4. Page 5. Page 6. Page 7. Page 8.

  9. Hematología - Ensayos clínicos - Mayo Clinic

    Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment. Despite not needing therapy, these patients ...

  10. Clínica de las mamas - Ensayos clínicos - Mayo Clinic

    This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...